Edelman Joseph

10% OwnerXTL BIOPHARMACEUTICALS LTD (XTLB) · full profile →Form 4 · filed Dec 3, 2008
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.7M
Net Open-Market Flow
-$5.7M
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 19, 2008Sell(S)9.6M$0.15$1.4M20.6M
Nov 18, 2008Sell(S)1.9M$0.14$272K700K
Nov 18, 2008Sell(S)400K$0.16$64K2.6M
Nov 18, 2008Sell(S)2.7M$0.15$404K30.2M
Nov 18, 2008Sell(S)24.7M$0.14$3.5M32.9M
Nov 18, 2008Sell(S)300K$0.15$45K0
Nov 18, 2008Sell(S)400K$0.15$60K300K
Nov 18, 2008Sell(S)30K$0.16$5K3.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000909012-08-001242) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about XTLB insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000909012-08-001242"
Ask your agent
Use Arkolith to summarize insider buying and selling at XTL BIOPHARMACEUTICALS LTD
over the last 90 days and cite the filings.